Thomas Herzog, MD

Thomas Herzog Columbia University Medical CenterDr. Thomas Herzog is the Director of Gynecologic Oncology and the Physicians & Surgeons Endowed Professor of Clinical Gynecology and Obstetrics. Dr. Herzog is also the Fellowship Director in Gynecologic Oncology for Columbia/Cornell.

He was recruited to Columbia University and New York Presbyterian after spending 11 years at Washington University School of Medicine in St. Louis where he was as an Associate Professor, and the Director of the Fellowship Training Program. He graduated from medical school at the University of Cincinnati and completed his residency at Good Samaritan Hospital in Cincinnati.  He completed his fellowship in Gynecologic Oncology at Washington University. He is board certified in both Obstetrics and Gynecology and Gynecologic Oncology. Clinical specialties include innovative cancer surgery, minimally invasive surgery. tumor suppressor genes, molecular genetics, cytokines, pre-invasive cervical cancer, and novel cancer treatments.

As an active participant in the Gynecologic Oncology Group (GOG), he has a keen interest in applying the principles learned from the lab to the clinical setting. He has served as a Principal Investigator in a number of GOG trials with a special emphasis in ovarian and endometrial cancers. Dr. Herzog has authored or co-authored over 200 peer-reviewed articles and lectures extensively. He serves on the editorial boards of Gynecologic Oncology, Obstetrics and Gynecology International, Hematology Oncology Times, and others. He has been the on the leadership council of the Society of Gynecologic Oncology and the Foundation for Women’s Cancer as well as on the Board of Governors for the American College of Surgeons.

Spotlight

Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.

Awareness

Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.

Research

The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.

Education

The next Ovarian Cancer Survivors Course will be Saturday, July 26, 2014 in Boston. For more information on courses, click here.